Results 111 to 120 of about 4,485,385 (359)

The diagnostic and prognostic value of C1orf174 in colorectal cancer [PDF]

BioImpacts
Introduction: Colorectal cancer (CRC) is among the lethal cancers, indicating the need for the identification of novel biomarkers for the detection of patients in earlier stages.
Elham Nazari, Ghazaleh Khalili-Tanha, Ghazaleh Pourali, Fatemeh Khojasteh-Leylakoohi, Hanieh Azari, Mohammad Dashtiahangar, Hamid Fiuji, Zahra Yousefli, Alireza Asadnia, Mina Maftooh, Hamed Akbarzade, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Gordon A Ferns, Godefridus J Peters, Elisa Giovannetti, Jyotsna Batra, Majid Khazaei, Amir Avan   +18 more
doaj   +1 more source

Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications

Dialogues in Clinical Neuroscience, 2018
Psychiatric patients have a greater risk of premature mortality, predominantly due to cardiovascular diseases (CVDs). Convincing evidence shows that psychiatric conditions are characterized by an increased risk of metabolic syndrome (MetS), a clustering ...
B. Penninx, Sjors M. M. Lange
semanticscholar   +1 more source

Serum level of gamma-glutamyl transferase as a biomarker for predicting stenosis severity in patients with coronary artery disease

Indian Heart Journal, 2018
Background: Gamma glutamyl transferase (GGT) is associated with pathogenesis of various diseases such as coronary artery disease (CAD). GGT activity displays an essential role in the catabolism of glutathione which is reported as a major antioxidant. The
Siavash Arasteh, Mohsen Moohebati, Amir Avan, Habibollah Esmaeili, Hamideh Ghazizadeh, Adeleh Mahdizadeh, Farzad Rahmani, Elham Mohamamdazade, Gordon A. Ferns, Mohammad Reza Parizadeh, Majid Ghayour-Mobarhan   +10 more
doaj   +1 more source

Age at menarche and its association with the metabolic syndrome and its components [PDF]

, 2011
The metabolic syndrome is a major public health challenge and identifies persons at risk for diabetes and cardiovascular disease. The aim of this study was to examine the association between age at menarche and the metabolic syndrome (IDF and NCEP ATP ...
Döring, Angela, Heier, Margit, Huth, Cornelia, Kowall, Bernd, Meisinger, Christa, Peters, Annette, Rathmann, Wolfgang, Stöckl, Doris, Stöckl, Heidi, Thorand, Barbara   +9 more
core   +1 more source

Quantitative Iron Measurements in the Basal Ganglia of NBIA Patients Using QSM: Insights From a Tertiary Center

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurodegeneration with brain iron accumulation (NBIA) comprises rare genetic disorders characterized by predominantly extrapyramidal symptoms and iron deposition in the basal ganglia. Conventional magnetic resonance imaging (MRI) detects qualitative changes but cannot accurately quantify iron accumulation. Quantitative susceptibility
Özge Uygun, Alpay Özcan, Fuat Kaan Aras, Evrim Bozdemir, Sibel Uğur İşeri, Koray Kırımtay, Arzu Karabay, Murat Gültekin, Nihan Hande Akçakaya, Orkhan Mammadov, Gülay Kır, Dilek İnce Günal, Neşe Tuncer, Fatma Betül Özdilek, Banu Özen Barut, Ercan Köse, Hülya Apaydın, Asuman Ali, Sultan Çağırıcı, Pınar Topaloğlu, Alp Dinçer, Zuhal Yapıcı   +21 more
wiley   +1 more source

Gender, Diet, and Metabolic Syndrome in Adolescents in Malang, East Java [PDF]

, 2016
BACKGROUND: Metabolic syndrome is a set of sympton causing degenerative disease. Metabolic syndrome is assesed based on individual body mass index, waist circumference, blood presure, triglyceride level, high density lipoprotein level, and fasting blood ...
Indarto, D. (Dono), Riswari, R. M. (Rizki)   +1 more
core   +1 more source

Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome

Nature, 2016
Obesity, insulin resistance and the metabolic syndrome are associated with changes to the gut microbiota; however, the mechanism by which modifications to the gut microbiota might lead to these conditions is unknown.
R. Perry, Liang Peng, N. A. Barry, G. Cline, Dongyan Zhang, Rebecca L. Cardone, K. Petersen, R. Kibbey, A. Goodman, G. Shulman   +9 more
semanticscholar   +1 more source

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebrospinal fluid (CSF) cell‐free mitochondrial DNA (cf‐mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf‐mtDNA levels, body composition, nutritional status, and metabolic biomarkers in PD. Methods CSF cf‐mtDNA levels, defined as the
Yasuaki Mizutani, Tsuyoshi Nakai, Yasuhiro Maeda, Reiko Ohdake, Atsuhiro Higashi, Toshiki Maeda, Ryunosuke Nagao, Sayuri Shima, Kazuya Kawabata, Akihiro Ueda, Mizuki Ito, Hirohisa Watanabe   +11 more
wiley   +1 more source

Moyamoya Disease and the Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo, Jeong‐Yong Shin, Rugyeom Lee, Jiwon Cheon, Ji Hun Kim, Doeun Kim, Jae‐Kyung Won, In‐Hwan Oh, Yunjong Lee, Tae‐Beom Ahn   +9 more
wiley   +1 more source

Reply to: vitamin D supplementation and hemoglobin: dosing matters in prevention/treatment of anemia

Nutrition Journal, 2021
Seyyed Mostafa Arabi, Golnaz Ranjbar, Leila Sadat Bahrami, Abdolreza Norouzy   +3 more
doaj   +1 more source